Compass Pathways vs Supernus Pharmaceuticals
Compass Pathways vs Supernus Pharmaceuticals, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Compass Pathways is on 57/100 and Supernus Pharmaceuticals on 60/100.
Where each one leads
Compass Pathways
- agent readiness: 48/100 against 41/100
- funding raised: $294M against $17.5M
Supernus Pharmaceuticals
- our overall score: 60/100 against 57/100
- headcount: 809 against 241
At a glance
| Measure | Compass Pathways | Supernus Pharmaceuticals |
|---|---|---|
| What it is | Accelerating patient access to evidence-based innovation in mental health. | Biopharmaceutical company developing and commercializing CNS disease treatments. |
| Category | Biotechnology, Healthcare, Mental Health, Pharmaceuticals | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Services | Services |
| Founded | 2018 | 2005 |
| Headquarters | London, United Kingdom | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Compass Pathways | Supernus Pharmaceuticals |
|---|---|---|
| Employees | 241 | 809 |
| Total funding | $294M | $17.5M |
| Latest round | IPO | Series A |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 39,951 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Compass Pathways | Supernus Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 60/100 |
| Traction | 60/100 | 56/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 31/100 | 15/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | 65/100 | 66/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Compass Pathways | Supernus Pharmaceuticals |
|---|---|---|
| Hosting | AWS | AWS |
| CDN | Cloudflare | Not detected |
| Frameworks | Next.js, Tailwind CSS | Tailwind CSS, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
Compass Pathways vs Supernus Pharmaceuticals: common questions
Which is better, Compass Pathways or Supernus Pharmaceuticals?
On our 0-100 score Supernus Pharmaceuticals rates higher (60/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Compass Pathways and Supernus Pharmaceuticals compare on the numbers?
Compass Pathways leads on agent readiness (48/100 against 41/100), funding raised ($294M against $17.5M). Supernus Pharmaceuticals leads on our overall score (60/100 against 57/100), headcount (809 against 241).
Read the full Compass Pathways review and pricing or the Supernus Pharmaceuticals review and pricing. You can also browse other Compass Pathways alternatives we track.